The Centre for Research and Information on Substance Abuse (CRISA), in collaboration with the Nigerian network of NGOs on drugs and the Association of Substance Abuse Professionals, will hold a National Symposium on drug abuse and drug control in Nigeria from 14-16 August 2013.
Studies that utilize various research methods to investigate any aspect of licit (e.g., alcohol, tobacco) or illicit (e.g., cannabis, cocaine, heroin) drug availability, use and dependence will be considered for presentation. These include epidemiologic studies, general population surveys, school surveys, special population studies, qualitative research, case studies, clinical trials, and meta-analysis.
The focus of the symposium will be on capacity building for research, hence young researchers in the social and health sciences and education and experienced researchers with new data to present are particularly invited to participate. The symposium will also provide the forum for the official launch of a Nigerian association of substance abuse professionals and a network of NGOs in drug demand reduction and control.
The event will be held at Uyo, Akwa Ibom State (specific venue to be announced later). It is open to researchers,
professionals in prevention and treatment, law enforcement officials, policymakers,
students, journalists, etc.
Abstract deadline: 31 May 2013 (Abstract should be in APA format and limited to 200 words)
Full paper:15 July 2013. Instructions on preparing the full paper will be sent with the abstract acceptance note.
Registration Fees: General: N20,000 on or before 30 June; N25,000 after 30 June. Fees will cover conference materials, lunch, coffee/tea, symposium dinner. Students: Early registration: N10,000 and N12,000 after 30 June.
Registration information will be posted online at the conference website.
Contact details: Okokon Umoh: Email: firstname.lastname@example.org, email@example.com
Phone: +234 802 756 1365
Secretariat: CRISA Office, 10 Okon Essien Close, Uyo,
Akwa Ibom State
Read here more information.
Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.